INTERNATIONAL PATENT: ATROGI AB FILES APPLICATION FOR "USE OF Β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING"

GENEVA, Nov. 24 -- ATROGI AB (Tomtebodavagen 6171 65 Solna) filed a patent application (PCT/EP2025/063616) for "USE OF Beta2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING" on May 16, 2025. With publication no. WO/2025/238248, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BENGTSSON, Tore (Gadolinitvagen 10185 94 Vaxholm)

Abstract: There is provided herein a method of treatment comprising: (i) a first treatment cycle comprising administration of a therapeutically effective amount of a therapeutic agent, or a ph...